Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial ; day:26 ; month:7 ; year:2016 ; pages:1-11
Graefe's archive for clinical and experimental ophthalmology ; (26.7.2016), 1-11
- Contributor
-
Eter, Nicole
Mohr, Andreas
Wachtlin, Joachim
Feltgen, Nicolas
Shirlaw, Andrew
Leaback, Richard
SpringerLink (Online service)
- DOI
-
10.1007/s00417-016-3431-x
- URN
-
urn:nbn:de:1111-201607283213
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eter, Nicole
- Mohr, Andreas
- Wachtlin, Joachim
- Feltgen, Nicolas
- Shirlaw, Andrew
- Leaback, Richard
- SpringerLink (Online service)
Other Objects (12)
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Prospective evaluation of intravitreal bevacizumab for ischemic central retinal vein occlusion
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion